EMEA Point-Of-Care Diagnostics Market To Reach $23.13 Billion By 2033

EMEA Point-Of-Care Diagnostics Market Growth & Trends

TThe EMEA point-of-care diagnostics market size is estimated to reach USD 23.13 billion by 2033, registering a CAGR of 6.2% from 2025 to 2033, according to a new report by Grand View Research, Inc. Incorporation of healthcare IT and telecommunication such as HealthVault concept by Microsoft plays an inevitable role in the development of the Point-of-Care (PoC) diagnostics market. The introduction of healthcare information systems such as Electronic Medical Records (EMR) has highly increased the market penetration rates of these diagnostic tests. 

Rising demand for home healthcare coupled with patient awareness levels and government initiatives aimed at reducing hospital stays and healthcare expenditure are anticipated to drive the Europe, Middle East, and Africa (EMEA) PoC diagnostics market growth. On account of growing demand for self-testing, companies have launched portable devices that are easy to use such as Pandora CDx point-of-care system by POC Medical Systems. 

Growing base of the geriatric population will widen the target consumer base. Aging heightens the risk of chronic diseases including cardiovascular, diabetes, and cancer. Growing base of geriatric population is anticipated to further increase the demand for continuous monitoring via facilities requiring point-of-care diagnostic products such as home healthcare and assisted living facilities.

 Request a free sample copy or view report summary: EMEA Point-Of-Care Diagnostics Market Report

EMEA Point-Of-Care Diagnostics Market Report Highlights

• By product, Glucose testing dominated with a market share of 32.8% in 2024. The market growth can be attributed to the rising prevalence of diabetes with an increasing number of individuals requiring regular glucose monitoring to manage their condition effectively.

• Based on product, the cancer markers are projected to grow at the fastest CAGR during the forecast period owing to the rising incidence of cancer which necessitated early and accurate detection methods to improve patient outcomes.

• By end-use, the clinics held the largest market share in 2024, due to the increasing prevalence of chronic and infectious diseases, requiring rapid and accurate diagnostic solutions.

• Based on end-use, the home healthcare facilities are projected to grow at a CAGR of 7.4% over the forecast period. The increasing incidence of chronic diseases such as diabetes, cardiovascular diseases, and respiratory conditions is one of the primary market drivers.

EMEA Point-Of-Care Diagnostics Market Segmentation

Grand View Research has segmented the EMEA point-of-care diagnostics market based on product, end-use, and region:

EMEA Point-Of-Care Diagnostics Product Outlook (Revenue, USD Million, 2021 - 2033)

• Glucose Testing

• Hb1Ac Testing

• Coagulation Testing

• Fertility/ Pregnancy

• Infectious Disease

  • HIV POC

  • Clostridium Difficile POC

  • HBV POC

  • Pneumonia or Streptococcus Associated Infections

  • Respiratory Syncytial Virus (RSV) POC

  • HPV POC

  • Influenza/ Flu POC

  • HCV POC

  • MRSA POC

  • TB and Drug-resistant TB POC

  • HSV POC

  • COVID-19

  • Other Infectious Diseases

• Cardiac Markers

• Thyroid Stimulating Hormone

• Hematology

• Primary Care Systems

• Decentralized Clinical Chemistry

• Feces

• Lipid Testing

• Cancer Marker

• Blood Gas/ Electrolytes

• Ambulatory Chemistry

• Drug of Abuse (DOA) Testing

• Autoimmune Diseases

• Urinalysis/ Nephrology

EMEA Point-Of-Care Diagnostics End-use Outlook (Revenue, USD Million, 2021 - 2033)

• Clinics

  • Pharmacy & Retail Clinics

  • Physician Office

  • Urgent Care Clinics

• Hospitals

• Home

• Assisted Living Healthcare Facilities

• Laboratory

EMEA Point-Of-Care Diagnostics Regional Outlook (Revenue, USD Million, 2021 - 2033)

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Middle East & Africa

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players in the EMEA Point-Of-Care Diagnostics Market

• F. Hoffmann-La Roche Ltd

• QIAGEN

• Danaher Corporation

• BD (Becton Dickinson)

• BIOMÉRIEUX

• Abbott

• Siemens Healthcare Private Limited

• Werfen

• Nova Biomedical

• Trividia Health, Inc.